Xin Lang Cai Jing·2025-09-01 08:17Group 1 - The three major indices in the stock market rose on September 1, with the Shenzhen Component Index increasing by 1.05%, the Shanghai Composite Index rising by 0.46%, and the ChiNext Index up by 2.29% [1] - The Shanxi stock sector showed an overall increase of 0.94%, influenced by the broader market trends [1] Group 2 - Three Shanxi-listed companies saw stock price increases of over 5%, with Dongjie Intelligent (300486) leading at a rise of 19.98%, followed by Yangmei Chemical (600691) at 7.95%, and Zhendong Pharmaceutical (300158) at 6.11% [2] Group 3 - Dongjie Intelligent Technology Group Co., Ltd. (300486) was established in 1995 and listed on the Shenzhen Stock Exchange's ChiNext in 2015. The company focuses on enhancing value creation efficiency in global manufacturing through smart logistics equipment, integrating advanced technologies such as 5G, big data, and artificial intelligence [3] - The main products of Dongjie Intelligent include smart logistics conveying systems, smart logistics warehousing systems, smart coating systems, and smart multi-story parking systems, along with comprehensive services in planning consultation, software system development, intelligent equipment design and manufacturing, and system integration [3] - Yangmei Chemical (600691) was founded on June 12, 2014, and is a subsidiary of the Lu'an Chemical Group. The company operates in traditional chemicals, new coal chemicals, fine chemicals, chemical equipment manufacturing, and trade, with main products including urea, methanol, and dibutyl alcohol [3][4] - As of 2023, Yangmei Chemical has a registered capital of 3.35 billion yuan and total assets exceeding 90 billion yuan, expanding into diversified businesses such as new energy equipment R&D, logistics services, and import-export trade through technological innovation and industrial investment [4] Group 4 - Zhendong Pharmaceutical (300158) is located in Changzhi City, Shanxi Province, and was established on November 15, 1995, with its stock listed on January 7, 2011. The company specializes in pharmaceutical manufacturing and sales, including anti-tumor drugs, cardiovascular drugs, and anti-infection drugs, as well as traditional Chinese medicine manufacturing and health consumer products [5]